CAPTRUST Financial Advisors’s China-Biotics, Inc. Common Stock CHBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-400
Closed 1792
2018
Q2
$0 Hold
400
﹤0.01% 1685
2018
Q1
$0 Hold
400
﹤0.01% 1444
2017
Q4
$0 Buy
+400
New ﹤0.01% 1298

CAPTRUST Financial Advisors's CHBT Position: Q3 2018 in Review

CAPTRUST Financial Advisors sold out of China-Biotics, Inc. Common Stock (CHBT) in Q3 2018, closing a stake of 400 shares.

CAPTRUST Financial Advisors first reported a position in CHBT in Q4 2017 and held it in 3 quarters. The position peaked at $0 in Q2 2018. 0 funds tracked by Wall St. Rank hold CHBT as of Q3 2018.

  • CAPTRUST Financial Advisors reported no remaining China-Biotics, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 400 China-Biotics, Inc. Common Stock shares in Q3 2018.
  • CAPTRUST Financial Advisors first reported a position in China-Biotics, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
  • CAPTRUST Financial Advisors's China-Biotics, Inc. Common Stock position peaked at $0 in Q2 2018.
  • 0 funds tracked by Wall St. Rank held China-Biotics, Inc. Common Stock as of Q3 2018.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2018, filed 15 Nov 2018.